Alvotech to Participate in Morgan Stanley Annual Sustainable Finance Summit
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan Stanley Annual Sustainable Finance Summit on May 22, 2023.
Alvotech is scheduled to hold a fireside chat on May 22, 2023 at 10:15 am ET and will host investor meetings at the conference.
Alvotech is committed to the promise of biosimilars, which expand patient access to medicines globally and contribute to the overall sustainability of healthcare systems by providing lower cost alternatives to high-priced biologic medicines.
Part of Alvotech’s commitment is understanding and mitigating any impact on the natural environment. All of the electrical power for Alvotech’s R&D and manufacturing operations is sourced from renewable hydro and geothermal sources, while heating is provided from renewable geothermal sources.
Alvotech also emphasizes gender equality and has received an annual equal pay certification since 2021. Alvotech’s recently issued Equality Report for 2022 and other information regarding key ESG indicators for 2020-2022 can be found on Alvotech’s dedicated web portal https://alvotech.com/corporate-sustainability.
Registration to listen to a webcast of the firesite chat is now open on: https://morganstanley.webcasts.com/starthere.jsp?ei=1610515&tp_key=d359806ef8. Following the event, a webcast of Alvotech’s fireside chat will be available in the Investors Section of Alvotech’s website under News and Events – Events and Presentations, for 90 days.
About Alvotech
Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products, and services, enabled by a fully integrated approach and broad in-house capabilities. Alvotech’s current pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. Alvotech’s commercial partners include Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd. (US), STADA Arzneimittel AG (EU), Fuji Pharma Co., Ltd (Japan), Advanz Pharma (EEA, UK, Switzerland, Canada, Australia and New Zealand), Cipla/Cipla Gulf/Cipla Med Pro (Australia, New Zealand, South Africa/Africa), JAMP Pharma Corporation (Canada), Yangtze River Pharmaceutical (Group) Co., Ltd. (China), DKSH (Taiwan, Hong Kong, Cambodia, Malaysia, Singapore, Indonesia, India, Bangladesh and Pakistan), YAS Holding LLC (Middle East and North Africa), Abdi Ibrahim (Turkey), Kamada Ltd. (Israel), Mega Labs, Stein, Libbs, Tuteur and Saval (Latin America) and Lotus Pharmaceuticals Co., Ltd. (Thailand, Vietnam, Philippines, and South Korea). Each commercial partnership covers a unique set of product(s) and territories. Except as specifically set forth therein, Alvotech disclaims responsibility for the content of periodic filings, disclosures and other reports made available by its partners. For more information, please visit www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.
CONTACTS
Alvotech Investor Relations and Global Communications
Benedikt Stefansson
alvotech.ir[at]alvotech.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Kallelse till årsstämma i Anoto Group AB (publ)1.6.2023 08:00:00 CEST | Pressemelding
Aktieägarna i Anoto Group AB (publ) (“Bolaget”), kallas härmed till årsstämma att äga rum fredagen den 30juni 2023kl. 10.00 i Setterwalls Advokatbyrås lokaler med adress Sturegatan 10 i Stockholm. Rätt att delta och anmälan Aktieägare som önskar att deltaga i årsstämman ska dels vara registrerad i eget namn i den av Euroclear Sweden AB förda aktieboken för Bolaget senast onsdagen den 21 juni 2023,dels anmäla sitt deltagande till Bolaget senast fredagen den 23 juni 2023. Anmälan om deltagande i årsstämman ska ske per telefon till +44 (0)758 4301260 eller via e-post till AGM@anoto.com. Vid anmälan ska namn, personnummer/organisationsnummer samt registrerat aktieinnehav uppges. Fullmakter, registreringsbevis och andra behörighetshandlingar bör för att underlätta inpasseringen vid stämman skickas till Bolaget via e-post till AGM@anoto.com senast fredagen den 23 juni 2023. Bolaget tillhandahåller fullmaktsformulär på Bolagets hemsida www.anoto.com. För att ha rätt att delta i stämman måste
Aegon completes sale of Central and Eastern European Businesses to VIG1.6.2023 08:00:00 CEST | Press release
The Hague, June 1, 2023 - Aegon today announces the completion of the divestment of its businesses in Poland and Romania to Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG) for EUR 125 million. This was the final step to complete the full sale of Aegon’s insurance, pension and asset management business in Central and Eastern Europe to VIG, following the closings of the divestments of the Hungarian and Turkish businesses. “We are very pleased that we have now finalized the full divestment of our Central and Eastern European businesses. As part of Aegon’s transformation and sharpened focus, the closing allows us to fully concentrate on the countries and business lines where we can add most value, while our former businesses will start their new chapter as part of VIG,” says Lard Friese, CEO of Aegon. “I would like to sincerely thank our employees in Hungary, Poland, Romania and Turkey for their important contributions to Aegon over the years and I wish them all the best in thei
Notice to attend the Annual General Meeting in Anoto Group AB (publ)1.6.2023 08:00:00 CEST | Press release
The shareholders of Anoto Group AB (publ) (the “Company”) are hereby invited to attend the Annual General Meeting (the “AGM”) to be held on Friday30 June 2023 at 10 a.m. at the premises of SetterwallsAdvokatbyrå, Sturegatan 10 in Stockholm, Sweden. Notification of participation Shareholders wishing to attend the AGM must be entered as shareholders in the share register maintained by Euroclear Sweden AB no later than on Wednesday 21 June 2023,notify the Company of their intention to participate no later than on Friday 23 June 2023. Attendance is to be notified by phone to +44 (0)758 430 12 60 or by e-mail to AGM@anoto.com. The notification should state name, social security number/corporate identification number and registered number of shares. To facilitate admittance to the AGM, proxies, registration certificates and other authorisation documents should be submitted to the Company by email to AGM@anoto.com no later than on Friday 23 June 2023. The Company provides proxy forms on the C
Van Lanschot Kempen successfully issued €500 million Soft Bullet Covered Bond1.6.2023 08:00:00 CEST | Press release
Amsterdam/’s-Hertogenbosch, the Netherlands, 1 June 2023 31 May 2023, Van Lanschot Kempen successfully issued a €500 million 3 year Soft Bullet Covered Bond with a 3.5% fixed coupon. The deal had a final order book of €2 billion and was placed with a broad range of European institutional investors. The transaction further strengthens and diversifies Van Lanschot Kempen’s funding profile. The bonds are rated AAA by Standard & Poor’s. Van Lanschot Kempen’s Soft Bullet Covered Bond Programme is Dutch law-based and backed by a pool of Dutch residential mortgage loans. It is registered with De Nederlandsche Bank and is both UCITS-compliant and CRD-compliant. Van Lanschot Kempen mandated BNP Paribas, DZ Bank, ING, LBBW and Rabobank as Joint Lead Managers for this transaction. Media Relations: +31 20 354 45 85; mediarelations@vanlanschotkempen.com Investor Relations: +31 20 354 45 90; investorrelations@vanlanschotkempen.com About Van Lanschot Kempen Van Lanschot Kempen is an independent, spec
PGS - Mediterranean Contract Award1.6.2023 08:00:00 CEST | Press release
June 1, 2023, Oslo, Norway: PGS is awarded a 3D exploration acquisition contract in the Mediterranean by a major international energy company. Ramform Hyperion is expected to mobilize for the survey late third quarter and the program has a total duration of approximately 70 days. “We are very pleased with this contract award, which improves our visibility into the fourth quarter. There is increasing exploration interest in the Mediterranean following recent discoveries in this prolific gas province, and this award builds on our successful campaign from the previous season,” says President & CEO in PGS, Rune Olav Pedersen. PGS announces contract awards and MultiClient projects as stock exchange releases if the contract has a value of $10 million or more, MultiClient projects with a duration of 2 months or more and strategically important contracts. FOR DETAILS, CONTACT:Bård Stenberg, VP IR & Corporate Communication Mobile: +47 992 45 235 *** PGS ASA and its subsidiaries (“PGS” or “the C